Northwest Biotherapeutics Inc (NASDAQ:NWBO)

7.37
Delayed Data
As of Feb 27
 -0.09 / -1.21%
Today’s Change
3.79
Today|||52-Week Range
10.64
+37.76%
Year-to-Date
No recent news for Northwest Biotherapeutics Inc.

Today’s Trading

Previous close7.46
Today’s open7.49
Day’s range7.30 - 7.60
Volume611,471
Average volume (3 months)469,630
Market cap$464.2M
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+65.03%
Earnings growth (this year)+8.50%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+4.79%
P/E ratioNM
Price/Sales153.15
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PGNXProgenics Pharmaceut...-0.12-1.81%
PRQRProQR Therapeutics N...-0.94-4.75%
DVAXDynavax Technologies...+0.10+0.57%
SRNESorrento Therapeutic...-0.34-2.56%
Data as of 4:00pm ET, 02/27/2015

Financials

Next reporting dateMarch 2, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$809.0K
Annual profit (last year)-$65.8M
Net profit margin-8,132.14%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account